Tealwood Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Tealwood Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,890	Closed	-$1.58M	–	135
2022 Q4	$1.58M	Sell	13,890 -1,333	-9%	-$111K	0.83%	43
2022 Q3	$942K	Buy	15,223 +90	+0.6%	+$6.29K	0.51%	100
2022 Q2	$1.21M	Sell	15,133 -370	-2%	-$35K	0.6%	77
2022 Q1	$1.63M	Sell	15,503 -241	-2%	-$23.5K	0.69%	52
2021 Q4	$1.7M	Sell	15,744 -468	-3%	-$51.1K	0.68%	59
2021 Q3	$1.78M	Buy	+16,212	New	+$1.68M	0.72%	47
2021 Q1	$1.67M	Sell	18,128 -74	-0.4%	-$6.25K	0.67%	53
2020 Q4	$1.33M	Sell	18,202 -1,315	-7%	-$97.7K	0.63%	72
2020 Q3	$1.52M	Sell	19,517 -195	-1%	-$13.4K	0.99%	39
2020 Q2	$1.1M	Buy	+19,712	New	+$843K	0.73%	51

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tealwood Asset Management's HZNP Position: Q1 2023 in Review

Tealwood Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 13,890 shares — an estimated $1.58M sold.

Tealwood Asset Management first reported a position in HZNP in Q2 2020 and held it in 10 quarters. The position peaked at $1.78M in Q3 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Tealwood Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Tealwood Asset Management sold 13,890 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $1.58M.
Tealwood Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 10 quarters.
Tealwood Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.78M in Q3 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Tealwood Asset Management's 13F filing for Q1 2023, filed 12 Apr 2023.